riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU

Recruiting Observational Study
Tracheostomy Complication Quality of Life
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Azienda Usl di Bologna · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age greater than 18 years * Presence of indication for tracheostomy Exclusion Criteria: * Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy
Contacts

Lorenzo Gamberini, MD

+393403550540

gamberini6@ausl.bologna.it

CONTACT